Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels

We have studied, in a prospective blinded fashion, the effects of regular and extended-release gemfibrozil on plasma lipoprotein and apolipoprotein (apo) levels in hypercholesterolemic subjects with decreased high density lipoprotein (HDL) cholesterol (C) levels. Study participants were men and wome...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis 1996-11, Vol.127 (1), p.113-122
Hauptverfasser:	Schaefer, Ernst J., Lamon-Fava, Stefania, Cole, Thomas, Sprecher, Dennis L., Cilla, Donald D., Balagtas, Cecile C., Rowan, Jean P., Black, Donald M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Aged, 80 and over Apolipoproteins - blood Apolipoproteins - drug effects Cholesterol Cholesterol, HDL - blood Cholesterol, HDL - drug effects Cholesterol, VLDL - blood Cholesterol, VLDL - drug effects Delayed-Action Preparations Double-Blind Method Female Follow-Up Studies Gemfibrozil Gemfibrozil - administration & dosage Gemfibrozil - therapeutic use High density lipoprotein Humans Hypercholesterolemia - blood Hypercholesterolemia - drug therapy Hypolipidemic Agents - administration & dosage Hypolipidemic Agents - therapeutic use Lipoproteins - blood Lipoproteins - drug effects Low density lipoprotein Male Middle Aged Prospective Studies Triglycerides Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!